These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI. Kim M, Higuchi T, Arisaka Y, Achmad A, Tokue A, Tominaga H, Miyashita G, Miyazaki H, Negishi A, Yokoo S, Tsushima Y. Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243 [Abstract] [Full Text] [Related]
3. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer. Sakurai Y, Kawai H, Iwano S, Ito S, Ogawa H, Naganawa S. J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138 [Abstract] [Full Text] [Related]
4. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18. Basu D, Siegel BA, McDonald DJ, Nussenbaum B. Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620 [Abstract] [Full Text] [Related]
5. Chronic myeloid leukemia detected on FDG PET/CT imaging in a patient with renal cell carcinoma. Varoglu E, Kaya B, Sari O. Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):43-5. PubMed ID: 23177344 [Abstract] [Full Text] [Related]
6. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases? Heusner T, Gölitz P, Hamami M, Eberhardt W, Esser S, Forsting M, Bockisch A, Antoch G. Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240 [Abstract] [Full Text] [Related]
7. Usefulness of F-18 FDG-PET in a long-term hemodialysis patient with renal cell carcinoma and pheochromocytoma. Ozawa N, Okamura T, Koyama K, Hamazawa Y, Senzaki H, Tanabe S, Ikemoto S, Inoue Y. Ann Nucl Med; 2007 Jun; 21(4):239-43. PubMed ID: 17581724 [Abstract] [Full Text] [Related]
9. Isolated facial muscle metastasis from renal cell carcinoma on F-18 FDG PET/CT. Kang S, Song BI, Lee HJ, Jeong SY, Seo JH, Lee SW, Ahn BC, Lee J, Lee HJ. Clin Nucl Med; 2010 Apr; 35(4):263-4. PubMed ID: 20305417 [No Abstract] [Full Text] [Related]
12. Diagnosing active inflammation in the SAPHO syndrome using 18FDG-PET/CT in suspected metastatic vertebral bone tumors. Inoue K, Yamaguchi T, Ozawa H, Okada K, Taki Y, Goto R, Kinomura S, Kaneta T, Fukuda H. Ann Nucl Med; 2007 Oct; 21(8):477-80. PubMed ID: 17952557 [Abstract] [Full Text] [Related]
13. MRI and PET/CT of patients with bone metastases from breast carcinoma. Grankvist J, Fisker R, Iyer V, Fründ ET, Simonsen C, Christensen T, Stenbygaard L, Ewertz M, Larsson EM. Eur J Radiol; 2012 Jan; 81(1):e13-8. PubMed ID: 21227614 [Abstract] [Full Text] [Related]
19. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R. Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575 [Abstract] [Full Text] [Related]